Suvaxyn Circo+MH RTU

Authorised

This medicine is authorised for use in the European Union

porcine circovirus and porcine enzootic pneumonia vaccine (inactivated)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Suvaxyn Circo+MH RTU : EPAR - Summary for the public

Product information

Suvaxyn Circo+MH RTU : EPAR - Product Information

Suvaxyn Circo+MH RTU : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Suvaxyn Circo+MH RTU
• Active substance:
  • inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 ORF2 protein
  • Inactivated Mycoplasma hyopneumoniae, strain P-5722-3
• International non-proprietary name (INN) or common name:
  porcine circovirus and porcine enzootic pneumonia vaccine (inactivated)

Pharmacotherapeutic group

Inactivated viral and inactivated bacterial vaccines

Authorisation details

• EMA product number:
  EMEA/V/C/003924

Assessment history

Changes since initial authorisation of medicine

Suvaxyn Circo+MH RTU : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Suvaxyn Circo+MH RTU : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Suvaxyn Circo + MH RTU

Adopted Reference Number: EMA/CVMP/511548/2015